|
|
Post by mango on Feb 21, 2020 11:57:59 GMT -5
|
|
|
|
Post by neil36 on Feb 21, 2020 16:00:36 GMT -5
Thanks for posting this Mango. I’m sure everyone here is shocked by these allegations.......NOT! |
|
|
|
Post by hellodolly on Feb 21, 2020 19:35:53 GMT -5
RICO is the FEDs way of saying...we have you buy your NADS! The pharma's will resist but come to their senses after all the bad publicity that will come out. They're going to look like slime fighting their prices in the media. When they fully comprehend how tight their balls are being squeezed in that vice, not to mention that the FEDs can go after corporate officers under RICO (which by the way is the FEDs vice grips), they will come to a settlement akin to today's announcement of the $3B fine against $WFC. I will go one step further and say we might see some sort of consent decree where there could be some sort of Federal monitoring of their Rx prices.
|
|
|
|
Post by mango on Feb 21, 2020 21:46:20 GMT -5
RICO is the FEDs way of saying...we have you buy your NADS! The pharma's will resist but come to their senses after all the bad publicity that will come out. They're going to look like slime fighting their prices in the media. When they fully comprehend how tight their balls are being squeezed in that vice, not to mention that the FEDs can go after corporate officers under RICO (which by the way is the FEDs vice grips), they will come to a settlement akin to today's announcement of the $3B fine against $WFC. I will go one step further and say we might see some sort of consent decree where there could be some sort of Federal monitoring of their Rx prices. Just search these companies names in the DoJ data base and be AMASED at the corruption!!! Meanwhile...I am up at the casino, up on MNKD stock (thank you Rooks).... BadabingbadaBOOM |
|
|
|
Post by rfogel on Feb 21, 2020 22:50:09 GMT -5
|
|
|
|
Post by longliner on Feb 22, 2020 0:12:36 GMT -5
One question you know the answer to.  |
|
|
|
Post by hellodolly on Feb 22, 2020 8:35:53 GMT -5
"The plaintiffs originally sued Sanofi, Novo Nordisk and Eli Lilly in 2017, arguing that the drugmakers engaged in an “arms race” to boost list prices. New Jersey federal judge Brian Martinotti waved through their claims that the companies violated state consumer protection laws, which means they'll have to fight those allegations in court. And though Martinotti tossed out the lawsuit's racketeering claims, the judge gave the plaintiffs a chance to refile them...Dozens of patients sued on behalf of insulin patients who must pay a share of prescription list prices for insulin, specifically pointing to those with no insurance, those in high-deductible health plans and those in Medicare’s Part D donut hole, among others. Steve Berman, co-lead counsel in the case, said in a statement the ruling "clears the way for us to begin obtaining discovery from the manufacturers and PBMs so we can shine the light on exactly what has driven insulin prices sky high." www.fiercepharma.com/pharma/insulin-pricing-class-action-lawsuit-to-proceed-against-sanofi-novo-and-lilly" This ruling blows the insulin racket wide open," Steve Berman, a plaintiffs' lawyer who is one of the leaders of the potential class-action case, told Bloomberg. The ruling "clears the way for us to begin obtaining discovery from the manufacturers and PBMs so we can shine the light on exactly what has driven insulin prices sky high." The opinion was brought by U.S. District Judge Brian Martinotti, who said "This Court finds plaintiffs have adequately alleged fraudulent, unfair or unconscionable conduct." www.beckershospitalreview.com/pharmacy/novo-nordisk-eli-lilly-and-sanofi-must-face-lawsuit-over-insulin-prices.html |
|
|
|
Post by prcgorman2 on Feb 22, 2020 11:08:04 GMT -5
Wait, what? Corruption regarding insulin amongst the big three? I’ve been told over and over on this board that this simply doesn’t happen and to stop being paranoid. Now I have to go back to being paranoid again.
|
|
|
|
Post by mnholdem on Feb 22, 2020 13:32:13 GMT -5
What pisses me off about all this? Sanofi priced Afrezza at what I thought at the time was an astronomical price. 2-3 months later, the Big 3 all raised their RAA prices to approximately the same level.
I had hoped that after Sanofi ended its deal with MannKind that the price of Afrezza would be restored to what Al Mann had initially suggested.
That didn’t happen and another huge opportunity was lost by management.
|
|
|
|
Post by longliner on Feb 22, 2020 15:35:39 GMT -5
What pisses me off about all this? Sanofi priced Afrezza at what I thought at the time was an astronomical price. 2-3 months later, the Big 3 all raised there RAA prices to approximately the same level. I had hoped that after Sanofi ended its deal with MannKind that the price of Afrezza would be restored to what Al Mann had initially suggested. That didn’t happen and another huge opportunity was lost by management. Way weave in blame management on a big three BP RICO thread. Good lord!! |
|
|
|
Post by agedhippie on Feb 22, 2020 16:35:33 GMT -5
Wait, what? Corruption regarding insulin amongst the big three? I’ve been told over and over on this board that this simply doesn’t happen and to stop being paranoid. Now I have to go back to being paranoid again. Paranoia about the corruption of the US pharma business specifically the PBM system? Absolutely, it's corrupt and that's not paranoia. What they are suing the insulin makers for is done by every pharma out there including Mannkind. It's just that insulin is sexy and will get headlines whereas statins - not so much. The problem here is the PBM system as it operates today. |
|
|
|
Post by rfogel on Feb 22, 2020 17:56:29 GMT -5
I suspect the fact that the big 3 have been cutting their retail pharmacy prices in half over the past few months is a reflection that their PBM deals are so sweet that they could care less about the minimal dent direct to patient sales will make.
|
|
|
|
Post by ktim on Feb 22, 2020 18:59:53 GMT -5
Wait, what? Corruption regarding insulin amongst the big three? I’ve been told over and over on this board that this simply doesn’t happen and to stop being paranoid. Now I have to go back to being paranoid again. I'll side with you on the fact our payment/pricing system is corrupt, and provides a great deal of ability for anti-competitive behavior. I think the paranoia some have is if they think Mannkind's competitors are also shorting the stock. |
|
|
|
Post by lennymnkd on Feb 22, 2020 19:07:03 GMT -5
Why their not !
|
|
|
|
Post by ktim on Feb 22, 2020 19:14:31 GMT -5
What pisses me off about all this? Sanofi priced Afrezza at what I thought at the time was an astronomical price. 2-3 months later, the Big 3 all raised their RAA prices to approximately the same level. I had hoped that after Sanofi ended its deal with MannKind that the price of Afrezza would be restored to what Al Mann had initially suggested. That didn’t happen and another huge opportunity was lost by management. The game with PBMs is to have a high "price" and offer them rebates for good placement... i.e. decreasing price doesn't get insurers to provide better coverage. Is your theory that MNKD could lower the price to attract cash paying patients enough to offset price decline with increased volume? What do you think is an appropriate cost per unit? |
|
